Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

141 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castration-resistant Prostate Cancer trial results

Recruiting

Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer

NCT06228053

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Recruiting

A Phase I Trial of A-CAR032 in Participants With mCRPC

NCT07344311

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Beijing GoBroad Hospital Beijing, Beijing Municipality, China
  • Tongji Hospital, Tongji Medical College of HUST Wuhan, Hubei, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
View Trial Details
Recruiting

Study With [225Ac]Ac-FL-020 in mCRPC Participants

NCT06492122

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Chao Family Comprehensive Cancer Center Irvine, California, United States
  • University of Stanford Stanford, California, United States
  • University Hospital of Cleveland Cleveland, Ohio, United States
View Trial Details
Recruiting

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

NCT07189403

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +12 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Columbia University New York, United States
  • Brown University Providence, Rhode Island, United States
  • Oncopole Claudius Regaud Toulouse, France
View Trial Details
Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

NCT06842498

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Western Regional Medical Center - City of Hope Phoenix Goodyear Goodyear, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
View all 20 locations
View Trial Details
Recruiting

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT07244341

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Newton, Massachusetts, United States
  • Cancer & Hematology Center Grand Rapids, Michigan, United States
View all 19 locations
View Trial Details
Recruiting

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

NCT05413850

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Biogenix Molecular LLC Miami, Florida, United States
  • NovaCure Health Miami, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • XCancer Omaha / Urology Cancer Center Omaha, Nebraska, United States
View all 21 locations
View Trial Details
Recruiting

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06879041

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site San Diego, California, United States
  • Research Site Miami, Florida, United States
  • Research Site Tampa, Florida, United States
View all 16 locations
View Trial Details
Recruiting

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

NCT04986423

Conditions
Metastatic Castration-resistant Prostate Cancer
Locations
  • California Research Institute Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Colorado Urology Lakewood, Colorado, United States
View all 31 locations
View Trial Details

Related conditions